Jeffrey D. Kearns
Jeffrey D. Kearns publishes mostly in Oncology, Molecular Biology and Immunology, on topics such as NF-κB Signaling Pathways, Immune Response and Inflammation and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #598,262 of 7,710,434 ranked researchers
- Rank in United States
- #205,244 of 1,627,098
- Works
- 68
- Citations
- 2.3k
- Citations per work
- 34.2
What does Jeffrey D. Kearns research?
Jeffrey D. Kearns's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (33%), Immunology and Microbiology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences3246.5%
- Health Sciences2537.3%
- Medicine2537.3%
- Everything else1116.2%
- 1Oncology20% of their works
- 2Molecular Biology20% of their works
- 3Immunology13% of their works
- 4Cancer Research13% of their works
- 5Radiology, Nuclear Medicine and Imaging11% of their works
- 6Pulmonary and Respiratory Medicine6% of their works
Research topics
Which keywords describe Jeffrey D. Kearns's research?
The keywords of their largest research topics: Inflammation, Cancer, Chemotherapy, NF-?B, Signaling, Pattern Recognition Receptors, Toll-like Receptors and Fc Receptors.
- Mutational Signatures
- KRAS Mutations
- STAT3
- EGFR Mutations
- HER2
- Therapeutic Antibodies
- Fc Receptors
- Pattern Recognition Receptors
- NF-?B
- Cancer
- Inflammation
- Chemotherapy
- Signaling
- Toll-like Receptors
- Targeted Therapy
- Breast Cancer
- ALK Inhibitors
- IL-6
- Cetuximab
- Cancer Genomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Inflammation343 topics
- Cancer222 topics
- Chemotherapy152 topics
- NF-?B141 topic
- Signaling141 topic
- Pattern Recognition Receptors121 topic
- Toll-like Receptors121 topic
- Fc Receptors111 topic
- Targeted Therapy112 topics
- Therapeutic Antibodies111 topic
- Breast Cancer91 topic
- HER291 topic
- ALK Inhibitors81 topic
- EGFR Mutations81 topic
- IL-681 topic
- STAT381 topic
- Cetuximab61 topic
- KRAS Mutations61 topic
- Cancer Genomics31 topic
- Mutational Signatures31 topic
Where does Jeffrey D. Kearns work?
Jeffrey D. Kearns's main affiliation in the publication record is Merrimack Pharmaceuticals (United States), United States.
How many publications and citations does Jeffrey D. Kearns have?
OpenAlex counts 68 works and 2,328 citations for Jeffrey D. Kearns, an h-index of 23, ranking #598,262 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jeffrey D. Kearns. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.